Marion McCourt
Corporate Officer/Principal chez REGENERON PHARMACEUTICALS, INC.
Fortune : 13 M $ au 31/03/2024
Profil
Marion McCourt is currently the Director at Girls On The Run International and the Executive Vice President-Commercial at Regeneron Pharmaceuticals, Inc. Ms. McCourt previously held positions as the President & Chief Executive Officer at AstraZeneca Canada, Inc., Independent Director at SCYNEXIS, Inc., Independent Director at CytomX Therapeutics, Inc., Vice President-US Commercial Operations at Amgen, Inc., Chief Operating Officer-United States Region at AstraZeneca PLC, Vice President-Managed Markets & Government at AstraZeneca Pharmaceuticals LP, Chief Operating Officer at Medivation LLC (California), and President & Chief Operating Officer at Sio Gene Therapies, Inc. Ms. McCourt obtained an undergraduate degree from Lafayette College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2024 | 13 339 ( 0,01% ) | 13 M $ | 31/03/2024 |
Postes actifs de Marion McCourt
| Sociétés | Poste | Début |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 12/02/2018 |
Girls On The Run International
 Girls On The Run International Miscellaneous Commercial ServicesCommercial Services Girls On The Run International is a non-profit organization based in Charlotte, NC that offers a physical activity-based positive youth development program for girls in 3rd-8th grade. The program's evidence-based curriculum focuses on developing competence, confidence, connection, character, caring, and contribution in young girls through lessons that incorporate running and other physical activities. The program has served over 2 million girls since its inception in 1996 and has councils in all 50 states and the District of Columbia. An independent study found that 97% of participants learned critical life skills that they continue to use at home, at school, and with their friends. Girls On The Run also offers Heart & Sole, an after-school program for girls in 6th-8th grade. | Director/Board Member | - |
Anciens postes connus de Marion McCourt
| Sociétés | Poste | Fin |
|---|---|---|
| SCYNEXIS, INC. | Director/Board Member | 18/09/2018 |
| CYTOMX THERAPEUTICS, INC. | Director/Board Member | 13/06/2018 |
| SIO GENE THERAPIES INC. | President | 12/02/2018 |
| MEDIVATION INC | Chief Operating Officer | 01/09/2016 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2016 |
Formation de Marion McCourt
| Lafayette College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Girls On The Run International
Girls On The Run International Miscellaneous Commercial ServicesCommercial Services Girls On The Run International is a non-profit organization based in Charlotte, NC that offers a physical activity-based positive youth development program for girls in 3rd-8th grade. The program's evidence-based curriculum focuses on developing competence, confidence, connection, character, caring, and contribution in young girls through lessons that incorporate running and other physical activities. The program has served over 2 million girls since its inception in 1996 and has councils in all 50 states and the District of Columbia. An independent study found that 97% of participants learned critical life skills that they continue to use at home, at school, and with their friends. Girls On The Run also offers Heart & Sole, an after-school program for girls in 6th-8th grade. | Commercial Services |
